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Although the proapoptotic BH3-only protein, Bim, is
required for deletion of autoreactive thymocytes,
Bim-deficient mice do not succumb to extensive
organ-specific autoimmune disease. To determine
whether other BH3-only proteins safeguard toler-
ance in the absence of Bim, we screened mice lack-
ing Bim as well as other BH3-only proteins. Most
strains showed no additional defects; however,
mice deficient for both Puma and Bim spontaneously
developed autoimmunity inmultiple organs, and their
T cells could transfer organ-specific autoimmunity.
Puma- and Bim-double-deficient mice had a striking
accumulation of mature, single-positive thymocytes,
suggesting an additional defect in thymic deletion
was the basis for disease. Transgenic mouse models
of thymocyte deletion by peripheral neoantigens
confirmed that the loss of Bim and Puma allowed
increased numbers of autoreactive thymocytes to
escape deletion. Our data show that Puma cooper-
ates with Bim to impose a thymic-deletion check-
point to peripheral self-antigens and cement the
notion that defects in apoptosis alone are sufficient
to cause autoimmune disease.
INTRODUCTION
The property of immunological tolerance is imposed and main-
tained by a number of mechanisms acting in a serial and overlap-
ping manner. One of the earliest mechanisms proposed and
defined experimentally was the deletion of potentially autoreac-
tive lymphocytes by apoptosis. Despite this precedence, the
extent to which deletional (apoptotic) mechanisms contribute
to tolerance remains an open question (reviewed by von
Boehmer and Melchers, 2010). Experiments that specifically
uncouple the apoptosis of lymphocytes from immunoreceptor
stimulation have proven an informative approach to this issue.
During their differentiation in the bone marrow (BM) or thymus,
immature B or T cells bearing a B or T cell receptor (BCR or TCR)
that recognizes self-antigens with an inappropriately high avidityImengage the ‘‘intrinsic’’ or ‘‘mitochondrial’’ pathway of apoptosis,
regulated by the Bcl-2 family of proteins (Strasser, 2005). Activa-
tion of the proapoptotic Bcl-2 family members, Bax and Bak,
disrupts the mitochondrial outer membrane to allow the release
of cytochrome c into the cytosol, leading to formation of the
apoptosome and the activation of caspases, which dismantle
the cell by cleaving hundreds of proteins (Strasser, 2005;
Strasser et al., 2011). In healthy cells, Bax and Bak activation
is strictly suppressed by the prosurvival members of the Bcl-2
family: Bcl-2, Bcl-xL, Mcl-1, A1, and Bcl-w. Certain cytotoxic
stimuli, such as growth-factor deprivation or high-avidity immu-
noreceptor signaling, cause the upregulation of a class of proap-
optotic Bcl-2 family members, the BH3-only proteins. Mice and
humans have eight BH3-only proteins—Bad, Bik, Bid, Hrk, Bim,
Noxa, Puma, and Bmf—all of which can bind to at least some
prosurvival Bcl-2 family members and trigger apoptosis when
overexpressed (Huang and Strasser, 2000; Strasser et al.,
2011). The BH3-only proteins initiate apoptosis by unleashing
Bax or Bak from their sequestration by the Bcl-2-like prosurvival
proteins and/or by directly activating Bax or Bak (Dewson and
Kluck, 2009). Importantly, different cell types have different
expression profiles of the pro- and antiapoptotic Bcl-2 family
members, and therefore similar stimuli may provoke a different
life-or-death outcome in distinct cell types.
Bim is required for deletion of autoreactive thymocytes,
mature T cells, and B cells (Bouillet et al., 2002; Davey et al.,
2002; Enders et al., 2003). Although there have been some con-
flicting data on the importance of Bim in superantigen-induced
thymocyte deletion (Bouillet et al., 2002 and Zhan et al., 2011
found that Bim was essential, whereas Jorgensen et al., 2007
did not), data from several different TCR-transgenic models
are in accord. Bim was found to be critical for the apoptosis of
autoreactive thymocytes in models that affect deletion at the
CD4CD8 double negative (Bouillet et al., 2002) and the
CD4+CD8+ double positive (DP) stages (Hu et al., 2009) and
during the DP to CD8+ single positive (SP) transition (Moran
et al., 2011; Suen and Baldwin, 2012). The latter studies em-
ployed a TCR-transgenic negative-selection system in which
the autoimmune regulator (Aire) mediated the presentation of
a model peripheral tissue antigen (PTA) produced by medullary
thymic epithelial cells (mTECs) (Anderson et al., 2005; Hubert
et al., 2011). The survival of Bim-deficient TCR-transgenic
thymocytes specific to the PTA indicated that Aire-dependent
tolerance to PTA also engages Bim-mediated deletion.munity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc. 451
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6x129SV background succumb to severe systemic lupus eryth-
ematosis-like systemic autoimmunity, they do not develop wide-
spread organ-specific autoimmunity akin to that observed in
Aire-deficient mice (Anderson et al., 2002).
This disjunction in the requirement of Bim for deletion and
tolerance advances propositions that (1) apoptotic deletion of
developing T and B cells is not required for tolerance, and
that other mechanisms (such as anergy or regulation) are suffi-
cient, and/or (2) that other apoptotic regulators can delete
dangerous clones and maintain tolerance. In this study, we
probe these possibilities by assaying organ-specific tolerance
following the compound loss of Bim and other BH3-only
proteins. We found that among the BH3-only proteins, only the
additional loss of Puma provoked significant organ-specific
autoimmune disease in a sensitized reconstitution model,
accompanied by increased T cell activation and organ-specific
autoantibodies. Importantly, spontaneous autoimmunity arose
in the peripheral organs of mice deficient in both Puma and
Bim, and their T cells were able to transfer disease. Moreover,
only the compound loss of Puma exacerbated the thymocyte
developmental defects observed in Bim-deficent mice and
substantially increased the numbers of autoreactive T cells that
escaped thymic deletion. Together, our findings reveal a critical
apoptotic checkpoint in thymocytes regulated by Bim and Puma
and compelling evidence that apoptotic deletion of autoreactive
thymocytes is indeed important for prevention of organ-specific
autoimmunity.
RESULTS
A Sensitized Screen for Organ-Specific Autoimmunity
Caused by Loss of BH3-Only Proteins
To determine whether the compound loss of Bim and other BH3-
only proteins in the hematopoietic system could lead to organ-
specific autoimmune disease, we employed a hematopoietic
reconstitution system in Rag1/mice. The lymphopenic condi-
tions in these hosts can accelerate the development of autoim-
munity when provided with immunocompetent precursors from
autoimmune-prone donors (Gleeson et al., 1996). As expected,
no lymphocytic infiltration was observed in the peripheral organs
of Rag1/ mice (see Experimental Procedures) 8 weeks after
reconstitution with T cell-depleted BM from wild-type (WT)
mice (Figure 1A). By contrast, Rag1/ mice reconstituted with
hematopoietic cells from Vav-BCL-2-transgenic mice, in which
the intrinsic pathway of apoptosis is severely impaired (Egle
et al., 2004), developed lymphocytic infiltration in the salivary
glands, lacrimal glands, stomach, lungs, liver, and pancreas (Fig-
ure 1A and data not shown). Infiltration was accompanied by
serum autoantibodies to target tissues, such as the acinar cells
of the submandibular salivary gland, bronchiolar epithelium of
the lung, and parietal cells of the stomach, indicating that an
autoimmune response had been instigated (Figure 1B). This
outcome indicates that in the lymphopenic setting the intrinsic
pathway of apoptosis is important for establishing and maintain-
ing tolerance of PTA.
Nevertheless, mice reconstituted with precursors from Bim-
deficient (Bcl2l11/) mice did not succumb to organ-specific
autoimmunity, although some peripheral-organ serum autoanti-452 Immunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc.bodies were elicited (Figures 1A and 1B). Therefore, we next
tested precursors from a variety of compound mutants lacking
Bim and other BH3-only proteins: Noxa (Pmaip1), Puma
(Bbc3), Bmf, Bid, or Bad (Hrk is not expressed in lymphocytes,
and loss of Bik has no impact on lymphocytes [Coultas et al.,
2004], even when combined with concomitant loss of Bim [Coul-
tas et al., 2005]). Transfer of hematopoietic progenitors from
Bmf/Bcl2l11/, Bid/Bcl2l11/, and Bad/Bcl2l11/
mice did not elicit organ-specific autoimmunity (data not shown).
Mice reconstituted with precursors from Pmaip1/Bcl2l11/
mice occasionally showed signs of mild lymphocytic infil-
tration of the salivary gland or lung, but other organs were
unaffected (Figure 1A). By contrast, mice reconstituted with
precursors from Bbc3/Bcl2l11/ mice demonstrated exten-
sive infiltrates in the liver, lungs, and pancreas, accompanied
by serum autoantibodies targeting these organs (Figures 1A
and 1B). Strikingly, the infiltration of the pancreas was associ-
ated with exocrine pancreatitis that sometimes completely
ablated acinar cells (in 4 of 12 mice) while leaving the endocrine
islets intact (Figure 1A). Serum autoantibodies from these mice
showed reactivity to the pancreatic vasculature and, occasion-
ally, to exocrine acinar cells (Figure 1B). This autoimmune profile
is reminiscent of the disease observed in Aire/ mice (Jiang
et al., 2005).
Given this contribution of Puma to organ-specific tolerance
with Bim deficiency, we also tested precursors from Bbc3/,
Bbc3/Pmaip1/, and Trp53/Bcl2l11/ mice (p53 activa-
tion can induce Puma [Nakano and Vousden, 2001; Yu et al.,
2001]) in this system, but we observed no significant autoim-
mune pathology (data not shown). Together, these data indicate
that in a lymphopenic setting Puma cooperates with Bim to
establish tolerance to PTA.
Spontaneous Organ-Specific Autoimmunity in Mice
Doubly Deficient in Puma and Bim
To assess whether this requirement for both Bim and Puma in
organ-specific tolerance extended to intact animals, we aged
cohorts of mice singly or doubly deficient in key BH3-only
proteins and examined a range of tissues for quantification of
infiltration to generate a cumulative clinical score of autoimmu-
nity (Gray et al., 2007b). Aged Aire/ mice served as a positive
control, exhibiting autoimmune infiltration in the salivary, pros-
tate, and Harderian glands and the retina, lungs, and ovaries,
as reported previously (Jiang et al., 2005) (Figure 2A). Mice lack-
ing either Noxa or Bad had little or no leukocyte infiltration of
peripheral organs (Figure 2A). Aged Bcl2l11/ mice occasion-
ally developed mild infiltration of the lung but, in general, ex-
hibited little autoimmunity (mean ± SEM, 1.7 ± 0.5). By contrast,
aged Bbc3/Bcl2l11/ mice developed significantly more
autoimmune infiltrates in more organs than did Bcl2l11/
mice (mean ± SEM, 4.2 ± 0.6), with clinical scores comparable
to those observed in Aire/ mice (Figure 2A). The distribution
of autoimmune infiltrate in organs from aged Bbc3/Bcl2l11/
mice was similar to that observed in the Rag1
/
reconstitution
model, although generally less severe (Figure 2B). The infiltration
of the salivary gland was accompanied by fibrinoid necrosis of
blood vessels, consistent with vasculitis that was occasionally
destructive in this organ. These features did not accompany
the lymphocytic infiltrates found in the lung, liver, or pancreas
Figure 1. Compound Loss of Bim and Other
BH3-Only Proteins Can Cause Organ-
Specific Autoimmune Disease
(A) H&E-stained sections of tissues from lethally
irradiated Rag1/ mice reconstituted with
hematopoietic precursors fromWT or Vav-BCL-2-
transgenic mice, or mice lacking the indicated
BH3-only proteins. Arrows indicate areas of
lymphocytic infiltration.
(B) Immunofluorescent staining of Rag1/mouse
tissues with serum from Rag1/ mice recon-
stituted with hematopoietic precursors fromWT or
Vav-BCL-2-transgenic mice, or mice lacking the
indicated BH3-only proteins. Autoantibody reac-
tivity is shown in green and nuclear DAPI staining
in blue. Images are representative of n = 4mice per
group. KO, knockout; DKO, double knockout; ND,
no data.
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Puma and Bim Cooperate in Thymocyte Deletion(Figure 2B and data not shown). Serum autoantibodies to these
tissueswere also detected, confirming the autoimmune nature of
the lymphocytic infiltrates observed (data not shown).
To determine whether T cells mediated the autoimmunity
observed, we performed adoptive transfer of T cells from WT
or young Bbc3/Bcl2l11/ mice into Rag1/ mice. After
8 weeks, we assayed infiltration of the pancreas, a signature
target organ in mice deficient in both Puma and Bim. T cells
transferred from WT mice did not cause pathology in the
pancreas, whereas those from Bbc3/Bcl2l11/ mice elicited
mild to severe exocrine pancreatitis (Figures 2C and 2D). Consis-
tent with a critical role for T cells in mediating the organ-specific
autoimmunity observed in Puma and Bim double-deficient mice,
we found increased levels of CD44hiCD62Llo effector memory
T cells in the spleen and lymph nodes, also a feature of Aire/
mice (Figure 2E) (Anderson et al., 2002). Together, these dataImmunity 37, 451–462, Seshow that mice deficient in both Puma
and Bim spontaneously develop T cell-
driven autoimmunity that is not observed
in Bim-deficient mice.
Among BH3-Only Proteins, Only the
Additional Loss of Puma Worsens
the Thymocyte Developmental
Defects in Bim-Deficient Mice
Thymocyte differentiation in Bcl2l11/
mice is abnormal, with a marked
reduction in DP thymocytes and corre-
sponding increases in CD4SP and
CD8SP T cells, consistent with autoreac-
tive cells evading thymic deletion (Bouillet
et al., 2002). Previous studies showed
that the single loss of any other BH3-
only protein does not disrupt thymocyte
differentiation (Kaufmann et al., 2007;
Labi et al., 2008; Ranger et al., 2003; Vil-
lunger et al., 2003 and data not shown).
However, the compound loss of both
Bim and Puma impaired thymocyte
differentiation markedly beyond what isobserved in Bcl2l11/ mice (Erlacher et al., 2006), indicating
that there are other roles for BH3-only proteins in thymocyte
apoptosis. For this reason, and the T cell-dependent organ-
specific autoimmunity observed in mice deficient in both Puma
and Bim, we performed a deeper analysis of thymocyte differen-
tiation in the absence of Bim and other BH3-only proteins.
We established BM chimeras in C57BL/6.Ly5.1 (Ly5.1) mice
using the various compound mutant mice as donors and
analyzed thymocyte differentiation 8 weeks later. In contrast to
the Rag1/ chimeras, Ly5.1 mice reconstituted with precursors
from Vav-BCL-2-transgenic or Bbc3/Bcl2l11/mice showed
no signs of autoimmunity at this time point (median survival is
extended to 206 days; K. Mason, D.H.D.G., A.S., and L.A.O.,
unpublished data), thereby excluding any possible impact of
peripheral autoimmunity on thymocyte subset composition. As
expected, Bim deficiency significantly reduced the proportionptember 21, 2012 ª2012 Elsevier Inc. 453
Figure 2. Spontaneous Organ-Specific Autoimmunity in
Bbc3–/–Bcl2l11–/– Mice
(A) Graph of the cumulative clinical scores of ten organs quantifying
autoimmune infiltration and destruction in aged mice deficient in the proteins
indicated. Groups were compared using an ANOVA with a multiple-
comparison Tukey’s post hoc test. *p < 0.05, ***p < 0.001. Mean ages at time
of analysis were: Aire/, 237 days (d237) (n = 11); Pmaip1/, d147 (n = 9);
Bad/, d165 (n = 7); Bcl2l11/, d141 (n = 8); Bad/Bcl2l11/, d166 (n = 5);
Pmaip1/Bcl2l11/, d153 (n = 13); and Bbc3/Bcl2l11/, d143 (n = 15).
(B) Representative images of H&E-stained sections of tissues taken from aged
Bbc3/Bcl2l11/ mice, with arrows indicating lymphocytic infiltration.
(C) Images of H&E-stained sections of pancreas taken from Rag1/ mice
that had been injected with T cells from WT or healthy Bbc3/Bcl2l11/
mice.
(D) Graph of the incidence and severity of pancreatitis inRag1/mice that had
been injected with T cells from WT or Bbc3/Bcl2l11/ mice (n = 8).
(E) CD44 versus CD62L expression on CD4+ splenic T cells, with the mean
proportion of activated CD44hiCD62Llo/ T cells shown.
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454 Immunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc.and number of DP thymocytes while increasing the CD4SP and
CD8SP mature cell subsets compared to WT controls (Figures
3A and 3B; Figure S1 available online) (Bouillet et al., 1999).
Mice reconstituted with precursors from Pmaip1/Bcl2l11/,
Bad/Bcl2l11/, Bid/Bcl2l11/, or Bmf/Bcl2l11/
mice exhibited no differences in thymocyte differentiation
compared to the Bcl2l11/ chimeras (Figures 3A and 3B).
Consistent with the observations of Erlacher et al. (2006), mice
reconstituted with precursors deficient in both Bim and Puma
showed an additional, substantial reduction in the percentage
of DP thymocytes compared to Bcl2l11/ chimeras as the
number and proportion of mature CD4SP and CD8SP cells
increased (Figures 3A, 3B, and S1B). This exacerbation of the
defects in thymocyte differentiation caused by hematopoietic
deficiency of both Puma and Bim was reflected by the reduced
ratio of DP:SP thymocytes (2.7 ± 0.1 in Bcl2l11/; 1.3 ± 0.1 in
Bbc3/Bcl2l11/ [mean ± SEM]; Student’s t test p > 0.0001).
Importantly, the loss of Puma alone had no discernible impact
on thymocyte differentiation (Erlacher et al., 2006 and data not
shown). Together, these data show that Puma is unique among
the BH3-only proteins in synergizing with Bim to execute the
apoptosis of thymocytes at the critical DP to SP transition,
when negative selection primarily occurs.
To further investigate how the intrinsic pathway of apoptosis
shapes thymocyte differentiation, we also constructed
chimeras from Bbc3/Pmaip1/Bcl2l11/ mice (Figures 3A,
3B, and S1). An additional impact on the DP to SP transition
was observed, showing that although Noxa can affect some
thymocyte apoptosis, Bim and/or Puma can fulfill this role.
Furthermore, Bbc3/Pmaip1/ chimeras showed no thymo-
cyte defects compared to WT controls, indicating that Bim
alone is sufficient to mediate the proapoptotic functions
exerted by Puma and Noxa during thymocyte differentiation
(Figures 3B and S1B). We also compared the thymocyte pheno-
type of Bbc3/Pmaip1/Bcl2l11/ chimeras with that of
Bax/Bak/ chimeras, in which the intrinsic pathway of
apoptosis is completely disabled. There were no differences
between these two groups (Figure 3B), indicating that the loss
of the three proapoptotic BH3-only proteins Puma, Noxa, and
Bim causes maximal impairment of thymocyte apoptosis
in vivo.
Figure 3. Only the Additional Loss of Puma Exacerbates Defects in Thymocyte Development in Bim-Deficient Mice
(A) CD4 versus CD8 expression profiles of thymocytes from lethally irradiated mice reconstituted with hematopoietic progenitors lacking the BH3-only proteins
indicated and analyzed 8 weeks later. Profiles are representative of four experiments (total n = 6–13). TKO, triple knockout.
(B) Thymocyte subset proportions in mice reconstituted with hematopoietic progenitors from mice lacking the BH3-only proteins indicated (means ± SEM).
Statistically significant differences among the proportions of DP thymocytes are shown, tested with a one-way ANOVA with multiple-comparison Tukey’s post
hoc test (***p < 0.0001).
(C) CD5 versus CD69 expression on DP thymocytes with the mean (± SEM) proportion of CD69+CD5hi thymocytes shown.
(D) CD69 versus CD24 expression on CD4SP thymocytes with the mean (± SEM) proportion of mature CD69CD24lo/ thymocytes shown.
(E) Qa2 versus CD24 expression on CD4SP thymocytes with the mean (± SEM) proportion of mature Qa2+CD24lo/ thymocytes shown.
(F) Graph of the numbers of FITC+ recent thymic emigrant (RTE) cells recovered from the spleens of mice 24 hr after intrathymic FITC injection, with
means ± SEM shown.
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Puma and Bim
The exacerbated accumulation of SP thymocytes in Bbc3/
Bcl2l11/ mice suggested that further impairment of deletion
was the basis of the organ-specific autoimmunity observed in
these mice. We therefore investigated the expression of a range
of markers associated with thymocyte selection events.
When thymocytes express an abTCR that engages self-pepti-
de:MHC complexes in the thymic cortex with moderate affinity,
they are rescued from apoptosis and commence differentiation
into SP cells while they migrate to the thymic medulla. To assess
whether the loss of BH3-only proteins affected the efficiency ofImDP positive selection, we examined the upregulation of CD69
and CD5, early indicators of TCR signaling. Surprisingly, we
found that the proportion of CD69+CD5hi DP thymocytes was
increased in the Bcl2l11/ chimeras compared to recipients
of WT BM, consistent with an increased rate of positive selection
(Figure 3C). Bbc3/Bcl2l11/ chimeras had a similar propor-
tion and number of CD69+ DP as the Bcl2l11/ chimeras
(Figures 3C, S1C, and S1D), suggesting that altered positive
selection was not the basis for the organ-specific autoimmunity.
In the absence of further TCR stimulation, positively selected
thymocytes downregulate CD69 following differentiation into
CD8SP or CD4SP cells. As SP thymocytes mature, theymunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc. 455
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S1P1-mediated egress from the thymus (Love and Bhandoola,
2011). However, in thymocytes expressing a TCR that interacts
with self-peptide:MHC complexes with high avidity, this matura-
tion is interrupted and they are usually induced to undergo
apoptosis (deletion) (Hogquist et al., 2005). Analysis of
Bcl2l11/ chimeras revealed a normal distribution of CD69+
CD24hi semimature and CD69CD24lo/ mature CD4SP thymo-
cytes, but Bbc3/Bcl2l11/ chimeras had an increased
proportion and number of mature CD69CD24lo/CD4SP cells
(Figures 3D, S1E, and S1F). The increase in mature SP
thymocyteswas confirmed by the detection of increased propor-
tions of Qa2+CD24lo/ and CD62L-expressing cells in Bbc3/
Bcl2l11/ compared to Bcl2l11/ chimeras (Figures 3E and
S1G). The increase in mature SP thymocytes in Bbc3/
Bcl2l11/ compared to Bcl2l11/ chimeras suggests that the
deletion of semimatureSP thymocytes hadbeen impaired, allow-
ing further maturation of thymocytes normally deleted in a Puma-
dependent manner. Importantly, we observed no reduction in
thymic dendritic cell (DC) numbers, proportions, or MHC II
expression in Bim-deficient or Puma- and Bim-deficient mice
(data not shown), ruling out defects in DCs as an explanation
for the aberrant thymocyte differentiation in these animals.
In light of this apparent disruption in SP thymocyte maturation,
it was important to assess T cell export from the thymus of
Bbc3/Bcl2l11/ chimeras. Therefore, we performed intrathy-
mic fluorescein isothiocyanate (FITC) injections of chimeras and
analyzed FITC+ recent thymic emigrants in the spleen 24 hr later.
Comparable numbers of T cells were exported from the thymi of
WT, Bcl2l11/, or Bbc3/Bcl2l11/ chimeras (Figure 3F),
indicating that no global alterations in thymic output had
occurred. Therefore, despite extensive perturbations to thymic
selection, similar numbers of T cells were exported in mice
deficient in both Bim and Puma.
Together with the autoimmunity observed in peripheral organs
of Bbc3/Bcl2l11/ mice, these data implicated a failure of
deletion in the medulla. Therefore, we went on to directly
examine whether deletion to PTA was impaired in mice deficient
in both Puma and Bim.
Loss of Puma, in Addition to Loss of Bim, Causes
Increased Persistence of Autoreactive Thymocytes
and T Cells
To addresswhether there is an auxiliary role for Puma supporting
Bim in the deletion of thymocytes reactive to PTA, we turned to
two well-established TCR-transgenic models of thymic deletion
driven by a neo-peripheral antigen (Anderson et al., 2005; Hubert
et al., 2011). RIP-mOVA transgenic mice express a membrane-
bound form of ovalbumin (mOVA) under the control of a rat
insulin promoter (RIP) that enforces expression in the pancreatic
beta cells, in the kidney, and in mTECs (Gallegos and Bevan,
2004). Therefore, when thymocytes expressing the OT-I TCR
(reactive to a fragment of mOVA presented by H2-Kb molecules)
develop in this setting, extensive deletion of OT-I CD8SP ensues
in the medulla (Anderson et al., 2005; Gallegos and Bevan, 2004;
Hubert et al., 2011). The transcriptional regulator Aire is required
for this deletion, which affects the expression (Hubert et al.,
2011) and/or presentation (Anderson et al., 2005) of mOVA in
the thymus.456 Immunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc.We constructed a series of hematopoietic chimeras using
T cell-depleted BM from WT OT-I, Bcl2l11/ OT-I, or
Bbc3/Bcl2l11/ OT-I mice introduced into C57BL/6 (B6)
mice (to assay positive selection) or RIP-mOVA+ hosts (to assay
deletion). Analysis of thymocytes expressing the OT-I TCR using
an H2-Kb-OVA tetramer revealed normal positive selection of
OT-I CD8SP thymocytes in the B6 chimeras, regardless of the
donor genotype (Figure 4A). As expected, there was complete
deletion of OVA-reactive CD8SP thymocytes in WT OT-I/RIP-
mOVA+ chimeras due to their encounter with cognate antigen
in the thymic medulla (Figure 4A) (Gallegos and Bevan, 2004).
In accord with recent studies (Moran et al., 2011; Suen and Bald-
win, 2012), we observed that Bim deficiency rescued many of
these thymocytes from deletion (Figure 4A). We found equivalent
numbers ofBcl2l11/OT-I thymocytes in both RIP-mOVA and
RIP-mOVA+ hosts, suggesting that most OT-I thymocytes that
would otherwise have been deleted by antigen encounter had
been rescued (Figures 4B and 4C).
Remarkably, Bbc3/Bcl2l11/ OT-I/RIP-mOVA+ chi-
meras contained almost twice the proportion and three times
the number of autoreactive OT-I CD8SP thymocytes recovered
from the Bcl2l11/ OT-I/RIP-mOVA+ chimeras (Figures 4B
and 4C). The proportion and numbers of OT-I thymocytes in
the Bbc3/Bcl2l11/ OT-I/RIP-mOVA+ chimeras exceeded
those observed in the Bbc3/Bcl2l11/ OT-I/B6 hosts, indi-
cating that, in the presence of antigen, autoreactive thymocytes
deficient in both Puma and Bim were able to expand further
(Figures 4B and 4C).
The changes to thymocyte selection observed with the
compound loss of Puma and Bimwere reflected in the periphery.
Under positive-selecting conditions, similar numbers of OT-I
CD8+ T cells appeared in the spleens of B6 mice receiving
WT or Bcl2l11/ OT-I precursors (Figures 4D–4F). Bbc3/
Bcl2l11/ OT-I/B6 chimeras had an increased percentage
and number of OT-I CD8+ T cells in their periphery. Under
deleting conditions, essentially noOT-I T cells escaped the thymi
of WT OT-I/RIP-mOVA+ chimeras. By contrast, a significant
proportion and number of splenic OT-I T cells with Bim defi-
ciency appeared, and these doubled when Puma was also
absent (Figures 4D–4F).
Interestingly, the OT-I CD8SP thymocytes that escaped dele-
tion in the RIP-mOVA+ chimeras receiving either Bcl2l11/OT-I
or Bbc3/Bcl2l11/ OT-I BM had downregulated the CD8
coreceptor and abTCR compared to their B6 controls (Figures
S2A and S2B). This downregulation of the abTCR and the core-
ceptor was also apparent in a population of SP thymocytes in
nontransgenic Bcl2l11/ and Bbc3/Bcl2l11/mice (Bouillet
et al., 2002 and Figure 3A).
Puma Is Required for the Deletion of Semimature
SP Thymocytes
To confirm and extend these findings to an MHC II-restricted
system, we performed similar experiments using the OT-II
TCR-transgenic model. Irradiated RIP-mOVA transgenic or B6
mice received T cell-depleted BM from WT OT-II, Bcl2l11/
OT-II, or Bbc3/Bcl2l11/ OT-II mice, and 8 weeks later,
OT-II T cell differentiation was analyzed in these chimeras with
antibodies to the Va2 and Vb5 (Va2/Vb5) components of the
OT-II TCR. Under the positive-selection conditions of the B6
Figure 4. Bim and Puma Are Required for Deletion of OT-I Thymocytes in RIP-mOVA+ Mice
(A) Representative dot plots of CD4 and CD8 expression gated on H2-Kb-OVA tetramer+ thymocytes from WT or RIP-mOVA+ chimeras that had been recon-
stituted with BM fromOT-I transgenic mice onWT, Bim-deficient, or Puma- and Bim-double-deficient backgrounds. The percentages of DP, CD4SP, and CD8SP
gated on H2-Kb-OVA+ thymocytes are shown.
(B and C) Mean percentages (B) and cell numbers (C) of H2-Kb-OVA+ CD8SP thymocytes (± SEM) from the various chimeras.
(D) H2-Kb-OVA versus CD8 staining on splenocytes from the various chimeras, with the proportion of H2-Kb-OVA+ CD8+ T cells shown.
(E andF)Meanpercentages (E) and numbers (F) ofH2-Kb-OVA+CD8+ splenocytes (±SEM) from the various chimeras. PBdenotesPumaandBimdouble deficient.
Groups composed of three to four mice were compared using Student’s t test; *p < 0.05, **p < 0.01, ***p < 0.001. Data from one of two experiments are shown.
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increased numbers of Va2/Vb5+ CD4SP thymocytes (Figures
5A and 5B).
Under negative-selection conditions in the RIP-mOVA+
chimeras, the proportion and number of CD4SP in recipients ofImWT OT-II BM were approximately half of those observed in
C57BL/6 chimeras, because the Va2/Vb5hi cells were deleted
(Figures 5A and 5B and data not shown). In RIP-mOVA+
chimeras, Bim deficiency restored the numbers of OT-II
CD4SP to those observed under conditions of positive selection.munity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc. 457
Figure 5. Both Bim and Puma Are Required
for the Deletion of Mature CD4SP OT-II
Thymocytes in RIP-mOVA+ Mice
(A) Representative dot plots of CD4 and CD8
expression gated on Va2/Vb5+ thymocytes from
RIP-mOVA or RIP-mOVA+ chimeras that had
been reconstituted with BM from OT-II transgenic
mice on WT, Bim-deficient, or Puma- and Bim-
double-deficient backgrounds. The percentages
of Va2/Vb5+ CD4SP thymocytes are shown.
(B and C) Mean percentages and cell numbers
of Va2/Vb5+ CD4SP thymocytes (B) or Va2/
Vb5+CD4+ splenocytes (C) (± SEM) from the
various chimeras.
(D) CD24 versus Qa2 expression on Va2/Vb5+
CD4SP thymocytes from the various chimeras.
Groups composed of three to four mice were
compared using Student’s t test; *p < 0.05,
**p < 0.01. Data from one of two experiments are
shown.
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splenic Va2/Vb5+CD4+ T cells (Figure 5C), indicating substantial
impairment of thymic deletion in the absence of Bim.
In accord with the OT-I system, Bbc3/Bcl2l11/ OT-II/
RIP-mOVA+ chimeras generated approximately twice the
number of OT-II CD4SP compared to B6 recipients (Figures 5A
and 5B). In contrast to recipients of WT or Bcl2l11/ OT-II
BM, many of the CD4SP in Bbc3/Bcl2l11/ OT-II/RIP-
mOVA+ chimeras exhibited a mature CD24loQa2+ phenotype
(Figure 5D). These data, as well as similar findings in the OT-I
system (data not shown), are consistent with the specific expan-
sion of mature SP thymocytes observed in nontransgenic
Bbc3/Bcl2l11/mice (Figure 3E). Analysis of bromodeoxyur-
idine (BrdU) incorporation 16 hr following injection revealed that
all chimeras had a similarly low level of dividing OT-II CD4SP,
indicating that the expansion of this subset in Bbc3/
Bcl2l11/ chimeras was not caused by increased proliferation
(Figure S3A). By contrast, thymocytes from mice deficient in
both Puma and Bim were more resistant to apoptosis provoked
by in vitro TCR stimulation than thymocytes from Bim-deficient
(or WT) mice, measured by both Annexin V and PI and active-
caspase-3 staining (Figures S3B–S3E). We also found that
TCR-stimulated thymocytes from Bbc3/Bcl2l11/ mice had
considerably lower Bak activation, measured using an antibody
that recognizes the active form of Bak (data not shown).
Together, these results suggest that the loss of Puma (in addition
to Bim) rescues CD4SP OT-II thymocytes that are normally
deleted at the CD24hiQa2 semimature stage of differentiation
via activation of the intrinsic pathway of apoptosis.
In summary, these data suggest that although Bim deficiency
alone can inhibit the deletion of PTA-reactive thymocytes,
compound loss of Bim plus Puma substantially enhances the
rescue of autoreactive thymocytes, allowing a greater number
to complete thymic maturation and emigrate to the periphery.
DISCUSSION
Bim is required for thymocyte deletion in a range of settings;
however, the absence of organ-specific autoimmunity in Bim-
deficient mice suggests that other apoptotic regulators play
a role in PTA-mediated deletion. This prediction was borne out
by our observations of organ-specific autoimmunity in Rag1/
mice reconstituted with precursors from Vav-BCL-2-transgenic
mice, in which the intrinsic pathway of apoptosis is potently
blocked. By reconstituting Rag1/ mice with hematopoietic
precursors from a range of compound mutant mice lacking
Bim and other BH3-only proteins, we found that only the
combined loss of Puma and Bim provoked a similar pathology
in this sensitized assay of autoimmunity. Importantly, aged
Bbc3/Bcl2l11/ mice spontaneously developed organ-
specific autoimmunity (albeit with a reduced severity), indicating
that Puma was unique among BH3-only proteins in synergizing
with Bim to impose deletional tolerance of peripheral tissues.
The autoimmunity inBbc3/Bcl2l11/micewas reminiscent
of that observed in Aire/ mice, but there are important differ-
ences in the pathologies and, presumably, the autoantigens
involved. For instance, retinopathy and serum autoantibodies
directed against the interphotoreceptor layer develop in Aire/
mice (Anderson et al., 2002) but were not observed in miceImdeficient in both Puma and Bim. Conversely, the lymphocytic
infiltration of the pancreas in Bbc3/Bcl2l11/ mice (which
became destructive in reconstituted Rag1/ mice) was not
observed in C57BL/6 Aire/ mice (Jiang et al., 2005). These
findings suggest that Puma and Bim are not required for deletio-
nal tolerance of all Aire-regulated PTA, and conversely, they can
affect tolerance to Aire-independent PTA.
Defects in T cell tolerance underpinned the autoimmunity we
observed in Bbc3/Bcl2l11/ mice. Their T cells showed
evidence of increased activation and could transfer autoimmu-
nity to Rag1/ recipients. In the thymus, Puma was again
unique among the BH3-only proteins in preventing further accu-
mulation of SP thymocytes in the absence of Bim. In fact,
increased numbers of mature CD69CD24lo/CD62L+Qa2+ SP
thymocytes was a prominent, distinguishing feature of Bbc3/
Bcl2l11/ mice in both the polyclonal and TCR-transgenic
settings. Evidence that this SP defect reflected impaired toler-
ance came from the TCR-transgenic models, wherein com-
pound deficiency in Puma and Bim in the OT-I and OT-II models
significantly increased the escape of PTA-reactive thymocytes
beyond that in Bcl2l11/ mice. Importantly, the increase could
not be attributed to an increased proliferative response to the
antigen, because there was no change in BrdU incorporation
by these cells. Rather, our data indicate that Puma is required
for normal deletion of semimature CD69+CD24hiCD62LQa2
SP thymocytes following high-avidity TCR stimulation, extending
upon Bim’s function in this process (Villunger et al., 2004).
Is the increased production of PTA-reactive T cells escaping
Puma- and Bim-mediated deletion driving the autoimmunity
observed in these mice? Defects in thymic deletion caused the
autoimmunity observed in Aire/ mice (reviewed in Taniguchi
and Anderson, 2011), without any requirement for ‘‘danger’’
signals or inflammation (Gray et al., 2007b). The PTA-mediated
deletion of OT-I and OT-II thymocytes was even more severely
affected inBbc3/Bcl2l11/mice than in Aire/mice (Ander-
son et al., 2005; Hubert et al., 2011), suggesting that the lesion to
central tolerance caused by crippling the intrinsic pathway of
apoptosis would be sufficient to explain the autoimmunity we
observed. In addition, there is good evidence that dominant
tolerance imposed by regulatory T (Treg) cells remains intact in
Bbc3/Bcl2l11/ mice (indeed, it may be amplified); CD25+
Treg cells from mice with deficiencies in the intrinsic pathway
of apoptosis function normally and are significantly increased
in number (Zhan et al., 2011), whereas conventional T cells
from Bbc3/Bcl2l11/ mice can be efficiently suppressed
(Szymczak-Workman et al., 2011). Therefore, the thymic produc-
tion of PTA-reactive T cells in mice deficient in Puma and Bim is
probably sufficient to provoke autoimmunity, overwhelming
peripheral tolerance mechanisms.
In contrast to Aire/ mice, thymocytes that avoid deletion in
Bbc3/Bcl2l11/ mice show evidence of antigen encounter
in the thymus (increased CD69 and reduced coreceptor expres-
sion). This stimulation would presumably increase the scope for
the induction of nondeletional negative-selection mechanisms,
which may explain the finding that Bbc3/Bcl2l11/ OT-I/
RIP-mOVA chimeras did not develop diabetes and exhibited
peripheral OT-I T cells with an anergic phenotype (consistent
with the data in Bcl2l11/ mice from Suen and Baldwin,
2012). Therefore, among the PTA-reactive clones that escapemunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc. 459
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nity, whereas others may become anergic or be diverted into
Treg cells. The next challenge is to elucidate the most important
synergies between nondeletional pathways and the physiolog-
ical mediators of deletion we have identified here.
The reason Puma is unique among BH3-only proteins in
providing an ancillary function in central tolerance is probably
because it can, like Bim, engage in strong interactions with all
of the prosurvival Bcl-2 proteins (Chen et al., 2005; Kuwana
et al., 2005). The increased expression of the antiapoptotic
Bcl-2 family members throughout late thymocyte differentiation
would require potent antagonism from BH3-only proteins for
efficient induction of apoptosis following high-avidity TCR inter-
actions in the medulla. The selective interactions of the other
BH3-only proteins (e.g., Noxa, Bmf, and Bad) with the prosur-
vival Bcl-2 family members or the requirement for death receptor
engagement (for Bid activation) might render them ineffective
for PTA-mediated thymocyte deletion. It is also possible that
direct activation of Bax and Bak might require the combination
of Puma and Bim (Dewson and Kluck, 2009). However, we also
found that the loss of Noxa, Puma, and Bim together was
required for phenocopying of the Bax/Bak/ chimeras. Given
that the combined loss of Bax and Bak completely cripples the
intrinsic apoptotic pathway, this observation indicates that
Bim, then Puma, and then Noxa are the major BH3-only proteins
involved in the life-and-death decisions that shape thymocyte
differentiation.
Our results also demonstrate that this important pathway is
extremely robust. The likelihood that the combination of loss-
of-function mutations necessary to completely ablate the
intrinsic pathway of apoptosis (i.e., to Noxa, Puma, and Bim or
to Bax and Bak) would manifest in thymocytes is extremely
low. It is more probable that partial defects in deletion and
anergy or T cell regulation could cooperate to drive autoimmune
disease (e.g., Teh et al., 2010). Understanding the molecular
bases of those tolerance mechanisms that synergize with dele-
tion should reveal better ways to deal with autoreactivity and
autoimmune disease.
EXPERIMENTAL PROCEDURES
Mice
All mice were housed at TheWalter and Eliza Hall Institute ofMedical Research
(WEHI) under specific pathogen-free conditions, and experiments were
carried out in accordance with the Animal Ethics Committee guidelines of
the Melbourne Directorate. Some of the gene-targeted mice (Pmaip1/,
Bbc3/, Bid/, and Bmf/) were generated on an inbred C57BL/6 back-
ground, using C57BL/6-derived embryonic stem cells. Other mice (Bad/,
Bcl2l11/, and Trp53/) were generated on a mixed C57BL/6x129SV back-
ground and then backcrossed to the C57BL/6 background >10 times prior to
intercrossing. The BM donor strains Bcl2l11/ and Trp53/ were back-
crossed 14 and 46 times to the C57BL/6 background, respectively. The Vav-
BCL-2-transgenic mice were generated on an inbred C57BL/6 background
(Ogilvy et al., 1999). Bcl2l11/ (Bouillet et al., 1999), Pmaip1/ (Villunger
et al., 2003), Bbc3/ (Villunger et al., 2003), Bid/ (Kaufmann et al., 2007),
Bmf/ (Labi et al., 2008), Bad/ (Ranger et al., 2003), Bax/ (Knudson
et al., 1995), Bak/ (Lindsten et al., 2000), and Trp53/ (Jacks et al., 1994)
mice were intercrossed for generation of the various compound mutant
mice. Vav-BCL-2 (Ogilvy et al., 1999), OT-I (Hogquist et al., 1994), OT-II (Barn-
den et al., 1998), and RIP-mOVA (Kurts et al., 1996) transgenic mice (all gener-
ated on a C57BL/6 background) have been described, and Rag1/ and
C57BL/6.Ly5.1 mice were obtained from WEHI Bioservices. For the assess-460 Immunity 37, 451–462, September 21, 2012 ª2012 Elsevier Inc.ment of spontaneous autoimmunity in aged mice, compound mutants were
taken when moribund for any reason (usually due to glomerulonephritis),
excluding leukemia. Bad/ or Pmaip1/ mice were taken when their
double-knockout littermates became sick.
Hematopoietic Reconstitution
For generation of hematopoietic chimeras, adult Rag1/ or B6.Ly5.1 mice
were irradiated with two doses of 5.5 Gy 3 hr apart and reconstituted by
intravenous injection of 0.5–1.03 107 T cell-depleted BM cells. T cell depletion
was performed on an autoMACS Cell Separator (Miltenyi Biotec, Cologne,
Germany) using biotinylated Thy-1 monoclonal antibody (mAb) (clone T24)
and streptavidin or anti-biotin microbeads according to the manufacturer’s
instructions. Mice received 100 mg of Thy1 mAb (clone T24) intraperitoneally
(i.p.) 24 hr following injection of BM cells to eliminate residual donor T cells
and were then left for 8 weeks prior to analysis.
Adoptive Transfer
Splenic T cells from either WT or healthy Bbc3/Bcl2l11/ mice were
isolated by staining with biotinylated Thy-1 mAb (clone T24), followed by
incubation with streptavidin microbeads and positive selection on an auto-
MACS according to the manufacturer’s instructions. Rag1/ mice received
1 3 106 T cells, and after 8 weeks, organs were harvested for histological
analysis, and flow-cytometric analysis of blood and spleen was performed
for confirmation that only donor-derived T cells were present.
Flow Cytometry
Single-cell suspensions of various organs were stained with fluorochrome- or
biotin-conjugated antibodies to the following markers (produced in our labora-
tory except where indicated): CD4 (BioLegend, clone GK1.5), CD8 (clone
YTS.169), TCRb (clone H57-597), TCRVb5 (BD Biosciences, clone MR9-4),
TCRVa2 (BDBiosciences, clone B20.1), CD44 (clone IM7), CD62L (BioLegend,
clone MEL-14), CD5 (BioLegend, clone 53-7.3), CD69 (BioLegend, clone
H1.2F3), CD24 (BioLegend, clone M1/69), Ly5.1 (clone A20), and Qa2
(BioLegend, clone 695H1-9-9). H-2Kb-OVA monomer was purchased from
A. Brooks (University of Melbourne) and tetramerized with streptavidin phyco-
erythrin (BD Biosciences). BrdU (Sigma-Aldrich) was administered via i.p.
injection (1 mg) and detected with AlexaFluor-647-conjugated anti-BrdU
(Invitrogen, clone MoBU-1) as described (Gray et al., 2007a). Apoptosis was
measured by Annexin V and PI staining or by active-caspase-3 (BD
Biosciences) staining of fixed and permeabilized thymocytes. Sample data
were acquired on an LSRII flow cytometer (BD Biosciences) and analyzed
using FloJo software (TreeStar).
Histology
Tissues were fixed in formalin, embedded, sectioned, and stained with hema-
toxylin and eosin (H&E), and infiltration was scored as described (Gray et al.,
2007b), with scores 0, 0.5, 1, 2, and 3 indicating none, trace, mild, moderate,
or severe lymphocytic infiltration and tissue destruction, respectively. The
organs analyzed included the eyes, Harderian glands, salivary glands, thyroid
glands, prostate glands or ovaries, stomach, pancreas, kidney, liver, and
lungs. For serum immunohistology, 8 mm sections of the indicated organs
were prepared from 7–10-week-old Rag1/ mice (for preclusion of back-
ground caused by endogenous immunoglobulin [Ig]) and stained with 1:100
dilutions of sera, followed by FITC-conjugated goat anti-mouse IgG antibodies
(Cappel) and DAPI (Sigma-Aldrich). Immunofluorescent images were acquired
using an LSM5 system (Zeiss).
Quantification of Recent Thymic Emigrants
C57BL/6.Ly5.1 hematopoietic chimeras grafted with BM cells from WT,
Bcl2l11/, or Bbc3/Bcl2l11/ mice were subjected to intrathymic FITC
injection as described (Berzins et al., 1998). Mice were then killed by CO2
asphyxiation 24 hr later, and single-cell suspensions of lymphoid organs
were stained with antibodies to Ly5.1, CD4, and CD8 for analysis on an LSRII
flow cytometer. Recent thymic emigrants were identified as FITC+ cells
expressing either CD4 or CD8 among live-gated cells, and the numbers of
emigrants were corrected for the extent of FITC labeling of thymocytes
(typically 50%–90%).
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Statistical comparisons weremade using one-way ANOVAwith a Tukey’s post
hoc test for multiple comparisons or a two-tailed Student’s t test with Prism
v.5.0 (GraphPad). p values <0.05 were considered to indicate a statistically
significant difference.
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